Addex Price to Sales

Stocks . USA . 
Stock . Addex Therapeutics
ADXN Stock  USD 0.68  0.0349  5.37%   
Addex Therapeutics fundamentals help investors to digest information that contributes to Addex Therapeutics' financial success or failures. It also enables traders to predict the movement of Addex Stock. The fundamental analysis module provides a way to measure Addex Therapeutics' intrinsic value by examining its available economic and financial indicators, including the cash flow records, the balance sheet account changes, the income statement patterns, and various microeconomic indicators and financial ratios related to Addex Therapeutics stock.
This module does not cover all equities due to inconsistencies in global equity categorizations. Continue to Equity Screeners to view more equity screening tools.
  
As of 1st of June 2023, Price to Sales Ratio is likely to grow to 2.67.

Addex Price to Sales Analysis

Addex Therapeutics' Price to Sales ratio is typically used for valuing equity relative to its own past performance as well as to performance of other companies or market indexes. In most cases, the lower the ratio, the better it is for investors. However, it is advisable for investors to exercise caution when looking at price-to-sales ratios across different industries.
 2020 2021 2022 2023 (projected)
Interest Expense650.63 K63.01 K313.26 K310.16 K
Gross Profit3.61 M2.92 M1.42 M2.16 M
P/S 
 = 
MV Per Share 
Revenue Per Share 
More About Price to Sales | All Equity Analysis

Current Addex Therapeutics Price to Sales

    
  10.28 X  
Most of Addex Therapeutics' fundamental indicators, such as Price to Sales, are part of a valuation analysis module that helps investors searching for stocks that are currently trading at higher or lower prices than their real value. If the real value is higher than the market price, Addex Therapeutics is considered to be undervalued, and we provide a buy recommendation. Otherwise, we render a sell signal.

Addex Price to Sales Driver Correlations

Understanding the fundamental principles of building solid financial models for Addex Therapeutics is extremely important. It helps to project a fair market value of Addex Stock properly, considering its historical fundamentals such as Price to Sales. Since Addex Therapeutics' main accounts across its financial reports are all linked and dependent on each other, it is essential to analyze all possible correlations between related accounts. However, instead of reviewing all of Addex Therapeutics' historical financial statements, investors can examine the correlated drivers to determine its overall health. This can be effectively done using a conventional correlation matrix of Addex Therapeutics' interrelated accounts and indicators.
Click cells to compare fundamentals

Addex Price to Sales Historical Pattern

Today, most investors in Addex Therapeutics Stock are looking for potential investment opportunities by analyzing not only static indicators but also various Addex Therapeutics' growth ratios. Consistent increases or drops in fundamental ratios usually indicate a possible pattern that can be successfully translated into profits. However, when comparing two companies, knowing each company's price to sales growth rates may not be enough to decide which company is a better investment. That's why investors frequently use a static breakdown of Addex Therapeutics price to sales as a starting point in their analysis.
   Addex Therapeutics Price to Sales   
       Timeline  
The most critical factor to remember is that the price of equity takes a firm's debt into account, whereas the sales indicators do not consider financial leverage. Generally speaking, Price to Sales ratio shows how much market values every dollar of the company's sales.
Competition

Addex Price to Sales Ratio

Price to Sales Ratio

2.67

Addex Therapeutics Price to Sales Ratio is very stable at the moment as compared to the past year. Addex Therapeutics reported last year Price to Sales Ratio of 2.60
Based on the latest financial disclosure, the price to sales indicator of Addex Therapeutics is roughly 10.2796 times. This is 51.96% lower than that of the Healthcare sector and 89.55% lower than that of the Biotechnology industry. The price to sales for all United States stocks is 9.99% higher than that of the company.

Addex Price to Sales Peer Comparison

Stock peer comparison is one of the most widely used and accepted methods of equity analyses. It analyses Addex Therapeutics' direct or indirect competition against its Price to Sales to detect undervalued stocks with similar characteristics or determine the stocks which would be a good addition to a portfolio. Peer analysis of Addex Therapeutics could also be used in its relative valuation, which is a method of valuing Addex Therapeutics by comparing valuation metrics of similar companies.
Addex Therapeutics is currently under evaluation in price to sales category among related companies.

Addex Therapeutics Current Valuation Drivers

We derive many important indicators used in calculating different scores of Addex Therapeutics from analyzing Addex Therapeutics' financial statements. These drivers represent accounts that assess Addex Therapeutics' ability to generate profits relative to its revenue, operating costs, and shareholders' equity. Below are some of Addex Therapeutics' important valuation drivers and their relationship over time.
201820192020202120222023 (projected)
Earnings Before Interest Taxes and Depreciation Amortization EBITDA(1.42 M)(14.23 M)(11.83 M)(14.94 M)(20.17 M)(20.7 M)
Earnings Before Interest Taxes and Depreciation Amortization USD(1.45 M)(14.67 M)(13.44 M)(16.42 M)(21.69 M)(22.26 M)
Earnings before Tax(1.64 M)(14.78 M)(12.86 M)(15.35 M)(20.8 M)(21.35 M)
Free Cash Flow1.74 M(9.51 M)(12.24 M)(14.74 M)(16.44 M)(16.87 M)
Invested Capital(1.79 M)(3.64 M)(1.57 M)(1.6 M)(1.58 M)(1.71 M)
Tangible Asset Value42.21 M33.03 M20.18 M22.54 M8.28 M8.5 M
Working Capital39.82 M26.71 M15.87 M17.81 M4.55 M4.67 M

Addex Fundamentals

Return On Equity(1.90) %
Return On Asset(0.83) %
Current Valuation3.12 M
Shares Outstanding14.81 M
Shares Owned by Institutions18.00 %
Number of Shares Shorted673.14 K
Price to Book1.41 X
Price to Sales10.28 X
Revenue1.42 M
Gross Profit1.44 M
EBITDA(20.17 M)
Net Income(20.8 M)
Cash and Equivalents8.81 M
Cash per Share1.40 X
Total Debt336.95 K
Debt to Equity0.049 %
Current Ratio2.55 X
Book Value Per Share0.38 X
Cash Flow from Operations(16.44 M)
Short Ratio0.71 X
Earnings Per Share(2.41) X
Number of Employees24
Beta1.67
Market Capitalization11.04 M
Total Asset8.28 M
Retained Earnings(349.86 M)
Working Capital4.55 M
Current Asset32.02 M
Current Liabilities4.82 M
Z Score-46.7
Net Asset8.28 M

About Addex Therapeutics Fundamental Analysis

The Macroaxis Fundamental Analysis modules help investors analyze Addex Therapeutics's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of Addex Therapeutics using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of Addex Therapeutics based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Please read more on our fundamental analysis page.
Last ReportedProjected for 2023
Price to Sales Ratio 2.60  2.67 

Be your own money manager

Our tools can tell you how much better you can do entering a position in Addex Therapeutics without increasing your portfolio risk or giving up the expected return. As an individual investor, you need to find a reliable way to track all your investment portfolios. However, your requirements will often be based on how much of the process you decide to do yourself. In addition to allowing all investors analytical transparency into all their portfolios, our tools can evaluate risk-adjusted returns of your individual positions relative to your overall portfolio.

Did you try this?

Run Headlines Timeline Now

   

Headlines Timeline

Stay connected to all market stories and filter out noise. Drill down to analyze hype elasticity
All  Next Launch Module

Pair Trading with Addex Therapeutics

One of the main advantages of trading using pair correlations is that every trade hedges away some risk. Because there are two separate transactions required, even if Addex Therapeutics position performs unexpectedly, the other equity can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Addex Therapeutics will appreciate offsetting losses from the drop in the long position's value.

Moving together with Addex Stock

+0.71EQEquillium Fiscal Quarter End 30th of June 2023 PairCorr
+0.71KAKineta Inc Symbol ChangePairCorr
+0.8YSYS Biopharma Report 2nd of June 2023 PairCorr

Moving against Addex Stock

-0.48VBLTVascular Biogenics Fiscal Quarter End 30th of June 2023 PairCorr
-0.44VECTVectivBio Holding Report 19th of July 2023 PairCorr
The ability to find closely correlated positions to Addex Therapeutics could be a great tool in your tax-loss harvesting strategies, allowing investors a quick way to find a similar-enough asset to replace Addex Therapeutics when you sell it. If you don't do this, your portfolio allocation will be skewed against your target asset allocation. So, investors can't just sell and buy back Addex Therapeutics - that would be a violation of the tax code under the "wash sale" rule, and this is why you need to find a similar enough asset and use the proceeds from selling Addex Therapeutics to buy it.
The correlation of Addex Therapeutics is a statistical measure of how it moves in relation to other equities. This measure is expressed in what is known as the correlation coefficient, which ranges between -1 and +1. A perfect positive correlation (i.e., a correlation coefficient of +1) implies that as Addex Therapeutics moves, either up or down, the other security will move in the same direction. Alternatively, perfect negative correlation means that if Addex Therapeutics moves in either direction, the perfectly negatively correlated security will move in the opposite direction. If the correlation is 0, the equities are not correlated; they are entirely random. A correlation greater than 0.8 is generally described as strong, whereas a correlation less than 0.5 is generally considered weak.
Correlation analysis and pair trading evaluation for Addex Therapeutics can also be used as hedging techniques within a particular sector or industry or even over random equities to generate a better risk-adjusted return on your portfolios.
Pair CorrelationCorrelation Matching
Check out Addex Therapeutics Piotroski F Score and Addex Therapeutics Altman Z Score analysis. To learn how to invest in Addex Stock, please use our How to Invest in Addex Therapeutics guide. You can also try Premium Stories module to follow Macroaxis premium stories from verified contributors across different equity types, categories and coverage scope.

Complementary Tools for Addex Stock analysis

When running Addex Therapeutics' price analysis, check to measure Addex Therapeutics' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Addex Therapeutics is operating at the current time. Most of Addex Therapeutics' value examination focuses on studying past and present price action to predict the probability of Addex Therapeutics' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Addex Therapeutics' price. Additionally, you may evaluate how the addition of Addex Therapeutics to your portfolios can decrease your overall portfolio volatility.
Global Markets Map
Get a quick overview of global market snapshot using zoomable world map. Drill down to check world indexes
Content Syndication
Quickly integrate customizable finance content to your own investment portal
Analyst Recommendations
Analyst recommendations and target price estimates broken down by several categories
Efficient Frontier
Plot and analyze your portfolio and positions against risk-return landscape of the market.
Positions Ratings
Determine portfolio positions ratings based on digital equity recommendations. Macroaxis instant position ratings are based on combination of fundamental analysis and risk-adjusted market performance
My Watchlist Analysis
Analyze my current watchlist and to refresh optimization strategy. Macroaxis watchlist is based on self-learning algorithm to remember stocks you like
Commodity Channel Index
Use Commodity Channel Index to analyze current equity momentum
Portfolio Rebalancing
Analyze risk-adjusted returns against different time horizons to find asset-allocation targets
Bollinger Bands
Use Bollinger Bands indicator to analyze target price for a given investing horizon
Is Addex Therapeutics' industry expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Addex Therapeutics. If investors know Addex will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Addex Therapeutics listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Earnings Share
(2.41) 
Revenue Per Share
0.192
Quarterly Revenue Growth
0.493
Return On Assets
(0.83) 
Return On Equity
(1.90) 
The market value of Addex Therapeutics is measured differently than its book value, which is the value of Addex that is recorded on the company's balance sheet. Investors also form their own opinion of Addex Therapeutics' value that differs from its market value or its book value, called intrinsic value, which is Addex Therapeutics' true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Addex Therapeutics' market value can be influenced by many factors that don't directly affect Addex Therapeutics' underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Altman
Z Score
Details
Piotroski
F Score
Details
Beneish
M Score
Details
Financial
Analysis
Details
Buy or Sell
Advice
Details
Technical
Analysis
Details
Please note, there is a significant difference between Addex Therapeutics' value and its price as these two are different measures arrived at by different means. Investors typically determine if Addex Therapeutics is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Addex Therapeutics' price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party. Check out Addex Therapeutics Piotroski F Score and Addex Therapeutics Altman Z Score analysis. To learn how to invest in Addex Stock, please use our How to Invest in Addex Therapeutics guide.


 
Macroaxis helps investors of all levels and skills to maximize the upside of all their holdings and minimize the risk associated with market volatility, economic swings, and company-specific events. View terms and conditions
 
Feedback Blog
Made with optimal in San Francisco
2023 Macroaxis LLC
COMMON DESTINATIONS
MAIN CATEGORIES
COMPANY